Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

MRKR

MRKR News

Newswire

09:20

Marker Therapeutics reports encouraging data for MT-601 in relapsed B cell lymphomas.

09:16

Marker Therapeutics to Present MT-601 Data at ASH Annual Meeting

07:34

Marker Therapeutics Initiates Phase 1 RAPID Study for OTS Immunotherapy

07:33

Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program with Encouraging Preliminary Safety Data.

16:10

Marker Therapeutics shares rise 2.06% after-hours following positive clinical data presentation at EASD.

View More

About MRKR

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More